Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

ema_building_face_web

EU approves Pfizer-BioNTech vaccine for 12-15 year olds

June 1, 2021 Manufacturing and Production, Sales and Marketing

The EMA has approved the Pfizer-BioNTech COVID-19 vaccine for 12-15 year olds. Individual EU member states can now decide if …
News
baby-2416718_1280

Five-month-old baby receives gene therapy Zolgensma on NHS

June 1, 2021 Manufacturing and Production, Sales and Marketing

A five-month-old baby is one of the first patients to receive Zolgensma, the world’s most expensive drug, on the NHS. …
News

CDC investigating post-vaccine inflammation reports in the US

May 24, 2021 Sales and Marketing

The US Centers for Disease Control (CDC) is looking in to a small number of reports that some young vaccine …
News

C. difficile infection Phase III trial meets primary endpoint

May 24, 2021 Sales and Marketing

Ferring Pharmaceuticals and Rebiotix have presented Phase III results demonstrating superior efficacy of investigational RBX2660 in reducing recurrence of Clostridioides …
News

FDA grants accelerated approval for Janssen’s lung cancer drug

May 24, 2021 Sales and Marketing

The FDA have granted accelerated approval of Rybrevant (amivantamab-vmjw) for the treatment of patients with metastatic non-small cell lung cancer …
News

Vaccines highly effective against Indian variant, study shows

May 24, 2021 Sales and Marketing

A new Public Health England (PHE) study shows that two doses of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine are …
News

BMS follow-up data sees long-term survival for melanoma patients

May 24, 2021 Sales and Marketing BMS, skin cancer

Bristol Myers Squibb (BMS) has announced follow-up data from their Phase III CheckMate-067 clinical trial, which demonstrated that 49% of …
News
facilities_lg06

Sputnik V COVID-19 vaccine launched in India by Dr Reddy’s

May 17, 2021 Sales and Marketing

Dr Reddy’s Laboratories has begun vaccinating in India with Russia’s COVID-19 vaccine as part of its soft launch after it …
News
sanofi_hq__boetie_hall_web

Sanofi and GSK’s COVID-19 vaccine shows promising results in Phase II trial

May 17, 2021 Sales and Marketing

The adjuvanted recombinant COVID-19 vaccine produced by Sanofi and GSK has demonstrated strong immune responses across all adult age groups …
News

Oxford University to collaborate with Oracle on COVID variant research

May 17, 2021 Sales and Marketing AI, COVID-19, Oxford, variants

In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …
News

PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes

May 17, 2021 Sales and Marketing AI, drug discovery

PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …
News
biogen_austria_238

Biogen fails to meet primary endpoint in XLRP study

May 17, 2021 Sales and Marketing Biogen, Clinical Trail

Biogen have released topline results from its Phase2/3 Xirius study of cotoretigene toliparvovec (BIIB112) as a gene therapy for patients …
News

Self-administered Crysvita receives positive CHMP opinion

May 10, 2021 Sales and Marketing CHMP, EMA

Kyowa Kirin’s drug for a rare metabolic bone disease, Crysvita, has received a positive opinion from the EMA’s Committee for …
News

NICE rejects Merck Serono’s Bavencio for urothelial cancer

May 10, 2021 Sales and Marketing MSD, Merck, NHS, NICE, cancer treatment, pharma, pharma news

The use of avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy is not recommended by …
News
GSK building

EMA begin review of GSK & Vir COVID-19 treatment

May 10, 2021 Sales and Marketing COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir

The EMA has begun a rolling review of GSK and Vir’s sotrovimab treatment for COVID-19, which will continue until there …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025